Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology
about
Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategyKynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantineAdvanced Boolean modeling of biological networks applied to systems pharmacology.A heuristic model for working memory deficit in schizophreniaEditorial: Schizophrenia: Human and Animal Studies.A perspective on multi-target drug discovery and design for complex diseases.
P2860
Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Assessing the synergy between ...... ntitative systems pharmacology
@ast
Assessing the synergy between ...... ntitative systems pharmacology
@en
type
label
Assessing the synergy between ...... ntitative systems pharmacology
@ast
Assessing the synergy between ...... ntitative systems pharmacology
@en
prefLabel
Assessing the synergy between ...... ntitative systems pharmacology
@ast
Assessing the synergy between ...... ntitative systems pharmacology
@en
P2093
P2860
P356
P1476
Assessing the synergy between ...... ntitative systems pharmacology
@en
P2093
Athan Spiros
Hugo Geerts
Patrick Roberts
P2860
P356
10.3389/FPHAR.2015.00198
P577
2015-09-22T00:00:00Z